(b) Overall survival
| Variables | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | ||
| Gender | Male/female | 3.218 (1.434–7.222) | 0.005* | 2.151 (1.889–14.047) | 0.001* |
| Age | ≥66/≤65 | 1.011 (0.473–2.162) | 0.977 | ||
| Tumor size | ≥33/<33 | 2.173 (1.019–4.630) | 0.044* | 1.725 (0.618–4.811) | 0.298 |
| T factor | T1/T2–T4 | 2.988 (1.204–7.415) | 0.018* | 0.801 (0.211–3.039) | 0.744 |
| Lymph node | +/− | 3.453 (1.614–7.391) | 0.001* | 1.858 (0.499–6.918) | 0.356 |
| P-stage | I/II-III | 4.533 (2.027–10.138) | <0.0001* | 1.492 (0.380–5.853) | 0.567 |
| ly factor | +/− | 3.865 (1.554–9.615) | 0.004* | 3.387 (0.894–12.836) | 0.073 |
| v factor | +/− | 2.303 (1.075–4.937) | 0.032* | 0.602 (0.226–1.607) | 0.311 |
| miR-210 | High/low | 0.235 (0.099–0.561) | 0.001* | 0.361 (0.127–1.031) | 0.057 |
CI: confidence interval.
* P < 0.05.